Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy

Pharmacotherapy

Volumn 28, Issue 12, 2008, Pages 1537-1541

  Sobieraj, Diana M ^a,b   Wang, Fei ^a,c   Kirton, Orlando C ^c,d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Community Health Center Inc   (United States)

^c HARTFORD HOSPITAL   (United States)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Absorption; Gastrectomy; Nutrition; Peptic ulcer disease; Roux en Y esophagojejunostomy; Stomach; Warfarin

Indexed keywords

ENOXAPARIN; HEPARIN; PANTOPRAZOLE; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG RESISTANCE; DRUG SOLUBILITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERIC FEEDING; ESOPHAGOJEJUNOSTOMY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALABSORPTION; PATIENT COMPLIANCE; PEPTIC ULCER; ROUX Y ANASTOMOSIS; STOMACH ADENOCARCINOMA; THROMBOSIS PREVENTION; TOTAL STOMACH RESECTION; VENOUS THROMBOEMBOLISM;

EID: 57149107581     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.12.1537     Document Type: Article

References (14)

1. Decker AG, Swain JM, Crowell MD, Scolapio JS. Gastrointestinal and nutritional complications after bariatric surgery. Am J Gastroenterol 2007;102:2571-80.
2. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health-Syst Pharm 2006;63:1852-7.
3. Eagon JC, Miedema BW, Kelley KA. Postgastrectomy syndromes. Surg Clin North Am 1992;72:445-65.
4. Shetty HGM, Fennerty AG, Routledge PA. Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokinet 1989;16:238-53.
5. Pyorala K, Jussila J, Mustala O, Sturala M. Absorption of warfarin from the stomach and small intestine. Scand J Gastroenterol Suppl 1971;9:95-103.
6. Brophy DF, Ford SL, Crouch MA. Warfarin resistance in a patient with short-bowel syndrome. Pharmacotherapy 1998;18:646-9.
7. Lutomski DM, LaFrance RJ, Bower RH, Fischer JE. Warfarin absorption after massive small-bowel resection. Am J Gastroenterol 1985;80:99-102.
8. Sverijnen R, Bayat N, Bakker H, Tolboom J, Bongaerts G. Enteral drug absorption in patients with short small bowel. Clin Pharmacokinet 2004;43:951-62.
9. Talstad I, Gamst ON. Warfarin resistance due to malabsorption. J Intern Med 1994;236:465-7.
10. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:204-23.
11. Nestlé Nutrition. Vivonex RTF product detail, April 2008. Available from http://www.nestle-nutrition.com/Products/Product.aspx?ProductId= 33478da1-b20a-4fc8-9113-b4b2c3082d0b. Accessed July 28, 2008.
12. United States Department of Agriculture. Dietary reference intakes: recommended intakes for individuals, March 2008. Available from http://fnic.nal.usda.gov/nal_display/index.php?info_center=4&tax_level= 3&tax_subject=256&topic_id=1342&level3_id=5140&level4_id= 0&level5_id=0&placement_default=0. Accessed July 28, 2008.
13. Penrod LE, Allen JB, Cabacungan LR. Warfarin resistance and enteral feedings: 2 case reports and supporting in vitro study. Arch Phys Med Rehabil 2001;82:1270-3.
14. Tovey FI, Hobsley M. Post-gastrectomy patients need to be followed up for 20-30 years. World J Gasteroenterol 2000;6:45-8.